What is Procter & Gamble Company's earnings per share (EPS)?

Procter & Gamble Company (PG) reported diluted earnings per share of $6.62 for fiscal year 2026. This represents a 1.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Procter & Gamble Company (PG) Financials

FY2026 annual

Revenue $87.0B +3.3% YoY

Net Income $16.0B +0.5% YoY

EPS (Diluted) $6.62 +1.7% YoY

Free Cash Flow $15.1B +7.9% YoY

Market Cap $351.3B as of Oct 10, 2026

Price / Sales 4.0x on $87.0B revenue, FY2026

Price / Earnings 21.9x on $16.0B net income, FY2026

Price / Book 6.5x on $54.3B equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the PG SEC filings page.

Procter & Gamble Company (PG) reported $87.0B in revenue for fiscal year 2026, up 3.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PG FY2026 2026-10-04

Modest sales growth produces recurring cash, while rising reinvestment and sub-1.0x liquidity shape P&G's financing model.

Revenue rose over the period, yet operating margin fell from 24.3% in FY2025 to 22.7% in FY2026. Gross margin also eased from 51.2% to 50.2%, so the latest profit slowdown reflects pressure below the gross-profit line as well as softer gross economics—not simply slower volume.

FY2026 net income of $16.0B converted into operating cash flow of $19.6B, showing earnings remained cash-backed. But capital spending has climbed over the period, so free cash flow has not risen in lockstep with operating cash flow; reinvestment is driving cash-generation variability.

A current ratio below 1.0x means current liabilities exceed current assets, indicating the operating model partly relies on short-term working-capital financing rather than holding a large current-asset buffer. Long-term debt declined in FY2026 even as dividends and buybacks totaled $15.4B against $15.1B of free cash flow, so distributions slightly exceeded that year's internally generated cash.

Financial Health Signals

Financial Health Score 62/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Procter & Gamble Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Procter & Gamble Company has an operating margin of 22.7%, meaning the company retains $23 of operating profit per $100 of revenue. This strong profitability earns a score of 93/100, reflecting efficient cost management and pricing power. This is down from 24.3% the prior year.

Growth

Procter & Gamble Company's revenue grew a modest 3.3% year-over-year to $87.0B. This slow but positive growth earns a score of 37/100.

Leverage

Procter & Gamble Company has a moderate D/E ratio of 0.42. This balance of debt and equity financing earns a leverage score of 58/100.

Liquidity

Procter & Gamble Company's current ratio of 0.68 is below the typical benchmark, resulting in a score of 8/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Procter & Gamble Company converts 17.4% of revenue into free cash flow ($15.1B). This strong cash generation earns a score of 83/100.

Returns

Procter & Gamble Company earns a strong 29.5% return on equity (ROE), meaning it generates $30 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 93/100. This is down from 30.6% the prior year.

Altman Z-Score Safe

5.51

Procter & Gamble Company scores 5.51, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($351.3B) relative to total liabilities ($72.2B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

6/9

Procter & Gamble Company passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.22x

For every $1 of reported earnings, Procter & Gamble Company generates $1.22 in operating cash flow ($19.6B OCF vs $16.0B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

22.52x

Procter & Gamble Company earns $22.52 in operating income for every $1 of interest expense ($19.7B vs $877.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$21.2B

YoY+1.5%

QoQ-0.2%

5Y CAGR+2.3%

10Y CAGR+2.8%

Procter & Gamble Company generated $21.2B in revenue in Q4 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

EBITDA

$4.8B

YoY-6.2%

QoQ-11.2%

5Y CAGR+2.3%

Procter & Gamble Company's EBITDA was $4.8B in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.2% from the same quarter a year earlier. Against the prior quarter it is down 11.2%.

Net Income

$3.0B

YoY-15.8%

QoQ-22.6%

5Y CAGR+0.9%

10Y CAGR+4.6%

Procter & Gamble Company reported $3.0B in net income in Q4 2026. This represents a decrease of 15.8% from the same quarter a year earlier. Against the prior quarter it is down 22.6%.

EPS (Diluted)

$1.26

YoY-14.9%

QoQ-22.7%

5Y CAGR+2.2%

10Y CAGR+6.2%

Procter & Gamble Company earned $1.26 per diluted share (EPS) in Q4 2026. This represents a decrease of 14.9% from the same quarter a year earlier. Against the prior quarter it is down 22.7%.

Cash & Balance Sheet

Free Cash Flow

$4.1B

YoY+3.0%

QoQ+35.8%

5Y CAGR+3.8%

10Y CAGR+3.7%

Procter & Gamble Company generated $4.1B in free cash flow in Q4 2026, representing cash available after capex. This represents an increase of 3.0% from the same quarter a year earlier. Against the prior quarter it is up 35.8%.

Cash & Debt

$9.9B

YoY+4.0%

QoQ-19.2%

5Y CAGR-0.7%

10Y CAGR+2.1%

Procter & Gamble Company held $9.9B in cash against $22.8B in long-term debt as of Q4 2026.

Dividends Per Share

$1.09

YoY+3.0%

QoQ+3.0%

5Y CAGR+4.6%

10Y CAGR+5.0%

Procter & Gamble Company paid $1.09 per share in dividends in Q4 2026. This represents an increase of 3.0% from the same quarter a year earlier. Against the prior quarter it is up 3.0%.

Shares Outstanding

2.32B

YoY-0.8%

QoQ-0.2%

5Y CAGR-0.9%

10Y CAGR-1.4%

Procter & Gamble Company had 2.32B shares outstanding in Q4 2026. This represents a decrease of 0.8% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Margins & Returns

Gross Margin

48.5%

YoY-0.6pp

QoQ-1.0pp

5Y change+0.2pp

Procter & Gamble Company's gross margin was 48.5% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.

Operating Margin

18.6%

YoY-2.2pp

QoQ-2.9pp

5Y change-0.1pp

10Y change+3.1pp

Procter & Gamble Company's operating margin was 18.6% in Q4 2026, reflecting core business profitability. This is down 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.9 percentage points.

Net Margin

14.4%

YoY-2.9pp

QoQ-4.2pp

5Y change-1.0pp

10Y change+2.2pp

Procter & Gamble Company's net profit margin was 14.4% in Q4 2026, showing the share of revenue converted to profit. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.2 percentage points.

Return on Equity

5.6%

YoY-1.3pp

QoQ-1.6pp

5Y change-0.6pp

10Y change+2.3pp

Procter & Gamble Company's ROE was 5.6% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.6 percentage points.

Capital Allocation

Share Buybacks

$875.0M

YoY+25.0%

QoQ+40.0%

5Y CAGR-21.8%

10Y CAGR+5.8%

Procter & Gamble Company spent $875.0M on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 25.0% from the same quarter a year earlier. Against the prior quarter it is up 40.0%.

Capital Expenditures

$1.0B

YoY+2.7%

QoQ+0.4%

5Y CAGR+7.5%

10Y CAGR-2.3%

Procter & Gamble Company invested $1.0B in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 2.7% from the same quarter a year earlier. Against the prior quarter it is up 0.4%.

R&D Spending

Not reported for Q4 2026.

PG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PG quarterly income statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$87.0B+3.3%	$84.3B+0.3%	$84.0B+2.5%	$82.0B+2.3%	$80.2B+5.3%	$76.1B+7.3%	$71.0B+4.8%	$67.7B+1.3%	$66.8B+2.7%	$65.1B-0.4%	$65.3B-7.7%	$70.7B+140.6%	$29.4B+0.7%	$29.2B+2.8%	$28.4B
Cost of Revenue	$43.4B+5.3%	$41.2B+0.8%	$40.8B-4.5%	$42.8B+1.4%	$42.2B+13.6%	$37.1B+5.3%	$35.3B+1.4%	$34.8B+1.0%	$34.4B+5.5%	$32.6B-1.2%	$33.0B-10.9%	$37.1B-5.1%	$39.0B+2.6%	$38.1B-8.1%	$41.4B
Gross Profit	$43.7B+1.3%	$43.1B-0.2%	$43.2B+10.1%	$39.2B+3.2%	$38.0B-2.5%	$39.0B+9.3%	$35.7B+8.5%	$32.9B+1.6%	$32.4B-0.1%	$32.4B+0.4%	$32.3B-4.2%	$33.7B+449.9%	-$9.6B-8.8%	-$8.9B+32.0%	-$13.0B
R&D Expenses	$2.1B0.0%	$2.1B+5.0%	$2.0B0.0%	$2.0B0.0%	$2.0B+5.3%	$1.9B+5.6%	$1.8B-5.3%	$1.9B0.0%	$1.9B0.0%	$1.9B0.0%	$1.9B-5.0%	$2.0B+5.3%	$1.9B0.0%	$1.9B-5.0%	$2.0B
SG&A Expenses	$23.9B+5.5%	$22.7B-2.7%	$23.3B+10.4%	$21.1B+4.4%	$20.2B-3.8%	$21.0B+5.2%	$20.0B+4.8%	$19.1B+0.2%	$19.0B+2.1%	$18.7B-1.9%	$19.0B-7.8%	$20.6B-3.9%	$21.5B-4.6%	$22.5B-13.4%	$26.0B
Operating Income	$19.7B-3.4%	$20.5B+10.3%	$18.5B+2.3%	$18.1B+1.8%	$17.8B-1.0%	$18.0B+14.5%	$15.7B+186.2%	$5.5B-58.9%	$13.4B-2.9%	$13.8B+3.8%	$13.3B+20.0%	$11.0B-20.6%	$13.9B+6.6%	$13.1B+0.1%	$13.0B
EBITDA	$22.9B-1.7%	$23.3B+8.7%	$21.4B+2.8%	$20.8B+1.1%	$20.6B-0.5%	$20.7B+10.7%	$18.7B+125.2%	$8.3B-48.7%	$16.2B-2.3%	$16.6B+1.5%	$16.3B+15.2%	$14.2B-16.8%	$17.1B+6.3%	$16.0B-1.3%	$16.2B
Interest Expense	$877.0M-3.3%	$907.0M-1.9%	$925.0M+22.4%	$756.0M+72.2%	$439.0M-12.5%	$502.0M+8.0%	$465.0M-8.6%	$509.0M+0.6%	$506.0M+8.8%	$465.0M-19.7%	$579.0M-7.5%	$626.0M-11.7%	$709.0M+6.1%	$668.0M-13.1%	$769.0M
Income Tax	$4.2B+3.2%	$4.1B+8.3%	$3.8B+4.8%	$3.6B+12.9%	$3.2B-1.9%	$3.3B+19.5%	$2.7B+29.9%	$2.1B-39.3%	$3.5B+13.1%	$3.1B-8.3%	$3.3B+22.6%	$2.7B-4.4%	$2.9B-6.9%	$3.1B-9.4%	$3.4B
Net Income	$16.0B+0.5%	$16.0B+7.4%	$14.9B+1.5%	$14.7B-0.6%	$14.7B+3.0%	$14.3B+9.8%	$13.0B+234.3%	$3.9B-60.0%	$9.8B-36.4%	$15.3B+45.9%	$10.5B+49.3%	$7.0B-39.6%	$11.6B+2.9%	$11.3B+5.2%	$10.8B
EPS (Basic)	$6.75+1.2%	$6.67+7.9%	$6.18+1.8%	$6.07+1.2%	$6.00+5.4%	$5.69+10.9%	$5.13+253.8%	$1.45-61.3%	$3.75-35.3%	$5.80+52.6%	$3.80+52.0%	$2.50-40.3%	$4.19+3.7%	$4.04+5.8%	$3.82
EPS (Diluted)	$6.62+1.7%	$6.51+8.1%	$6.02+2.0%	$5.90+1.5%	$5.81+5.6%	$5.50+10.9%	$4.96+246.9%	$1.43-61.0%	$3.67-34.3%	$5.59+51.5%	$3.69+51.2%	$2.44-39.2%	$4.01+3.9%	$3.86+5.5%	$3.66
Diluted Shares (Avg)	2.42B-1.3%	2.45B-0.7%	2.47B-0.5%	2.48B-2.2%	2.54B-2.4%	2.60B-0.9%	2.63B+3.4%	2.54B-4.4%	2.66B-3.1%	2.74B-3.7%	2.84B-1.4%	2.88B-0.7%	2.90B-0.9%	2.93B-0.4%	2.94B

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Revenue	$21.2B+1.5%	$21.2B+7.4%	$22.2B+1.5%	$22.4B+3.0%	$20.9B+1.7%	$19.8B-2.1%	$21.9B+2.1%	$21.7B-0.6%
Cost of Revenue	$10.9B+2.7%	$10.7B+10.6%	$10.8B+4.0%	$10.9B+4.5%	$10.6B+2.7%	$9.7B-1.6%	$10.4B+2.7%	$10.4B-0.8%
Gross Profit	$10.3B+0.3%	$10.5B+4.3%	$11.4B-0.8%	$11.5B+1.6%	$10.3B+0.7%	$10.1B-2.5%	$11.5B+1.5%	$11.3B-0.5%
SG&A Expenses	$6.3B+7.3%	$5.9B+7.5%	$6.0B+5.0%	$5.6B+2.2%	$5.9B-6.3%	$5.5B-6.1%	$5.7B+3.6%	$5.5B-1.5%
Operating Income	$4.0B-9.3%	$4.6B+0.4%	$5.4B-6.5%	$5.9B+1.0%	$4.4B+12.1%	$4.6B+2.2%	$5.7B+29.5%	$5.8B+0.5%
EBITDA	$4.8B-6.2%	$5.4B+2.2%	$6.2B-4.3%	$6.6B+1.4%	$5.1B+9.3%	$5.2B+1.5%	$6.4B+25.1%	$6.5B+0.9%
Interest Expense	$237.0M+11.8%	$223.0M+2.8%	$220.0M-8.3%	$197.0M-17.2%	$212.0M-3.2%	$217.0M-6.9%	$240.0M-3.2%	$238.0M+5.8%
Income Tax	$851.0M-4.9%	$1.0B+19.7%	$1.1B-8.2%	$1.3B+8.8%	$895.0M+23.3%	$868.0M+6.9%	$1.2B+18.3%	$1.2B-7.5%
Net Income	$3.0B-15.8%	$3.9B+4.3%	$4.3B-6.7%	$4.8B+20.0%	$3.6B+15.3%	$3.8B+0.4%	$4.6B+33.5%	$4.0B-12.4%
EPS (Basic)	$1.28-15.2%	$1.66+5.1%	$1.82-6.2%	$2.00+21.2%	$1.51+17.1%	$1.58+1.3%	$1.94+34.7%	$1.65-12.7%
EPS (Diluted)	$1.26-14.9%	$1.63+5.8%	$1.78-5.3%	$1.95+21.1%	$1.48+16.5%	$1.54+1.3%	$1.88+34.3%	$1.61-12.0%
Diluted Shares (Avg)	N/A	2.42B-1.4%	2.42B-1.4%	2.44B-1.2%	N/A	2.45B-0.9%	2.46B-0.4%	2.47B-0.4%

Not reported in any period shown, so not listed: R&D Expenses.

PG Balance Sheet

PG quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$126.5B+1.0%	$125.2B+2.3%	$122.4B+1.3%	$120.8B+3.1%	$117.2B-1.8%	$119.3B-1.2%	$120.7B+4.9%	$115.1B-2.7%	$118.3B-1.7%	$120.4B-5.3%	$127.1B-1.8%	$129.5B-10.2%	$144.3B+3.6%	$139.3B+5.3%	$132.2B
Current Assets	$26.2B+3.2%	$25.4B+2.8%	$24.7B+9.1%	$22.6B+4.6%	$21.7B-6.2%	$23.1B-17.5%	$28.0B+24.5%	$22.5B-3.6%	$23.3B-12.0%	$26.5B-21.6%	$33.8B+14.0%	$29.6B-6.2%	$31.6B+31.8%	$24.0B+9.5%	$21.9B
Cash & Equivalents	$9.9B+4.0%	$9.6B+0.8%	$9.5B+15.0%	$8.2B+14.3%	$7.2B-29.9%	$10.3B-36.4%	$16.2B+281.7%	$4.2B+65.0%	$2.6B-53.9%	$5.6B-31.2%	$8.1B+18.5%	$6.8B-20.0%	$8.5B+44.1%	$5.9B+33.7%	$4.4B
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0-100.0%	$6.0B-34.8%	$9.3B-3.0%	$9.6B+53.2%	$6.2B+31.0%	$4.8B+124.0%	$2.1B	$0	$0
Inventory	$8.2B+8.2%	$7.6B+7.6%	$7.0B-0.8%	$7.1B+2.2%	$6.9B+15.7%	$6.0B+8.8%	$5.5B+9.6%	$5.0B+5.9%	$4.7B+2.5%	$4.6B-2.0%	$4.7B-5.3%	$5.0B-19.8%	$6.2B-10.2%	$6.9B+2.8%	$6.7B
Accounts Receivable	$6.1B-2.1%	$6.2B+1.1%	$6.1B+11.8%	$5.5B+6.4%	$5.1B+8.8%	$4.7B+13.1%	$4.2B-15.6%	$5.0B+5.7%	$4.7B+2.0%	$4.6B+5.1%	$4.4B-4.3%	$4.6B-24.3%	$6.0B-7.3%	$6.5B+7.3%	$6.1B
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$41.3B-0.9%	$41.6B+3.3%	$40.3B-0.9%	$40.7B+2.4%	$39.7B-3.0%	$40.9B+2.6%	$39.9B-0.9%	$40.3B-10.9%	$45.2B+1.1%	$44.7B+0.8%	$44.4B-0.6%	$44.6B-12.0%	$50.7B-3.0%	$52.3B-2.8%	$53.8B
Total Liabilities	$72.2B-1.0%	$72.9B+1.6%	$71.8B-2.6%	$73.8B+4.8%	$70.4B-3.2%	$72.7B-1.6%	$73.8B+9.3%	$67.5B+3.2%	$65.4B+1.2%	$64.6B-6.5%	$69.2B+4.1%	$66.4B-10.6%	$74.3B+5.3%	$70.6B+3.4%	$68.2B
Current Liabilities	$38.7B+7.3%	$36.1B+7.2%	$33.6B-6.0%	$35.8B+8.1%	$33.1B-0.2%	$33.1B+0.5%	$33.0B+9.9%	$30.0B+6.3%	$28.2B-6.5%	$30.2B-1.8%	$30.8B+3.3%	$29.8B-11.7%	$33.7B+12.3%	$30.0B+20.6%	$24.9B
Non-Current Liabilities	$33.5B-9.1%	$36.9B-3.4%	$38.2B+0.5%	$38.0B+2.0%	$37.3B-5.7%	$39.5B+6845.7%	$569.0M-15.8%	$676.0M+1.5%	$666.0M-23.4%	$870.0M+8.2%	$804.0M+6.5%	$755.0M-1.9%	$770.0M-8.0%	$837.0M-6.1%	$891.0M
Long-Term Debt	$22.8B-8.6%	$25.0B-1.1%	$25.3B+3.7%	$24.4B+6.7%	$22.8B-1.1%	$23.1B-1.9%	$23.5B+15.4%	$20.4B-2.2%	$20.9B+15.7%	$18.0B-4.8%	$18.9B+3.4%	$18.3B-7.5%	$19.8B+3.6%	$19.1B-9.3%	$21.1B
Total Equity	$54.3B+3.9%	$52.3B+3.4%	$50.6B+7.4%	$47.1B+0.5%	$46.9B+0.4%	$46.7B-0.5%	$46.9B-1.5%	$47.6B-10.0%	$52.9B-5.2%	$55.8B-3.8%	$58.0B-8.0%	$63.0B-9.9%	$70.0B+1.8%	$68.7B+7.3%	$64.0B
Retained Earnings	$135.9B+4.5%	$130.0B+5.0%	$123.8B+4.8%	$118.2B+5.1%	$112.4B+5.7%	$106.4B+6.1%	$100.2B+5.6%	$94.9B-3.8%	$98.6B+2.6%	$96.1B+9.3%	$88.0B+3.7%	$84.8B-0.2%	$85.0B+6.0%	$80.2B+6.4%	$75.3B

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Total Assets	$126.5B+1.0%	$128.4B+4.4%	$127.3B+3.8%	$127.6B+0.9%	$125.2B+2.3%	$123.0B+2.8%	$122.6B+1.6%	$126.5B+3.2%
Current Assets	$26.2B+3.2%	$28.0B+14.5%	$26.6B+3.7%	$27.1B-1.2%	$25.4B+2.8%	$24.4B+8.8%	$25.6B+11.0%	$27.4B+10.1%
Cash & Equivalents	$9.9B+4.0%	$12.3B+35.0%	$10.8B+5.8%	$11.2B-8.1%	$9.6B+0.8%	$9.1B+33.5%	$10.2B+29.7%	$12.2B+24.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$8.2B+8.2%	$7.9B+6.1%	$7.8B+11.4%	$7.8B+7.7%	$7.6B+7.6%	$7.4B+4.6%	$7.0B-1.8%	$7.3B+2.4%
Accounts Receivable	$6.1B-2.1%	$6.3B+3.0%	$6.3B+0.7%	$6.5B+2.7%	$6.2B+1.1%	$6.1B+0.2%	$6.2B-1.6%	$6.3B+1.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$41.3B-0.9%	$41.4B+2.2%	$41.7B+4.4%	$41.6B+1.6%	$41.6B+3.3%	$40.5B-0.2%	$39.9B-2.5%	$41.0B+1.8%
Total Liabilities	$72.2B-1.0%	$73.6B+4.6%	$74.0B+3.9%	$74.0B-0.4%	$72.9B+1.6%	$70.4B+1.7%	$71.2B-1.0%	$74.3B-0.2%
Current Liabilities	$38.7B+7.3%	$38.2B+11.6%	$36.7B+8.6%	$38.0B+4.3%	$36.1B+7.2%	$34.2B+5.9%	$33.8B-6.0%	$36.4B-2.0%
Non-Current Liabilities	$33.5B-9.1%	$35.4B-2.2%	$37.3B-0.3%	$36.1B-4.9%	$36.9B-3.4%	$36.2B-2.0%	$37.4B+4.1%	$37.9B+1.5%
Long-Term Debt	$22.8B-8.6%	$23.9B-1.6%	$25.6B+1.2%	$24.3B-5.6%	$25.0B-1.1%	$24.3B0.0%	$25.3B+9.4%	$25.7B+7.0%
Total Equity	$54.3B+3.9%	$54.7B+4.2%	$53.3B+3.6%	$53.6B+2.7%	$52.3B+3.4%	$52.5B+4.4%	$51.4B+5.4%	$52.1B+8.6%
Retained Earnings	$135.9B+4.5%	$135.4B+5.0%	$134.0B+5.0%	$132.2B+5.5%	$130.0B+5.0%	$128.9B+4.7%	$127.5B+4.9%	$125.4B+4.1%

PG Cash Flow Statement

PG quarterly cash flow statement

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$19.6B+9.8%	$17.8B-10.2%	$19.8B+17.8%	$16.8B+0.7%	$16.7B-9.0%	$18.4B+5.6%	$17.4B+14.2%	$15.2B+2.5%	$14.9B+16.6%	$12.8B-17.4%	$15.4B+5.7%	$14.6B+4.7%	$14.0B-6.2%	$14.9B+12.0%	$13.3B
Depreciation & Amortization	$3.2B+11.0%	$2.8B-1.7%	$2.9B+6.7%	$2.7B-3.3%	$2.8B+2.6%	$2.7B-9.2%	$3.0B+6.7%	$2.8B-0.4%	$2.8B+0.5%	$2.8B-8.4%	$3.1B-1.8%	$3.1B-0.2%	$3.1B+5.3%	$3.0B-6.9%	$3.2B
Stock-Based Compensation	$524.0M+10.1%	$476.0M-15.3%	$562.0M+3.1%	$545.0M+3.2%	$528.0M-2.2%	$540.0M-3.2%	$558.0M+8.3%	$515.0M+30.4%	$395.0M+12.5%	$351.0M+4.8%	$335.0M-0.6%	$337.0M-6.4%	$360.0M+4.0%	$346.0M-8.2%	$377.0M
Capital Expenditures	$4.4B+16.9%	$3.8B+13.6%	$3.3B+8.5%	$3.1B-3.0%	$3.2B+13.2%	$2.8B-9.3%	$3.1B-8.2%	$3.3B-10.0%	$3.7B+9.8%	$3.4B+2.1%	$3.3B-11.3%	$3.7B-2.9%	$3.8B-4.0%	$4.0B+1.1%	$4.0B
Free Cash Flow	$15.1B+7.9%	$14.0B-15.0%	$16.5B+19.9%	$13.8B+1.6%	$13.6B-12.9%	$15.6B+8.8%	$14.3B+20.5%	$11.9B+6.7%	$11.2B+19.0%	$9.4B-22.7%	$12.1B+11.5%	$10.9B+7.5%	$10.1B-6.9%	$10.9B+16.6%	$9.3B
Investing Cash Flow	-$4.6B-21.1%	-$3.8B-9.0%	-$3.5B-0.1%	-$3.5B+20.9%	-$4.4B-56.1%	-$2.8B-193.1%	$3.0B+187.2%	-$3.5B+0.6%	-$3.5B+47.5%	-$6.7B-46.0%	-$4.6B-58.4%	-$2.9B+29.5%	-$4.1B+35.0%	-$6.3B-477.5%	-$1.1B
Financing Cash Flow	-$14.5B-3.0%	-$14.0B+5.5%	-$14.9B-22.3%	-$12.1B+18.4%	-$14.9B+30.9%	-$21.5B-157.3%	-$8.4B+16.3%	-$10.0B+30.5%	-$14.4B-67.8%	-$8.6B+7.0%	-$9.2B+29.2%	-$13.0B-78.9%	-$7.3B-2.9%	-$7.1B+32.1%	-$10.4B
Dividends Paid	$10.2B+3.6%	$9.9B+6.0%	$9.3B+3.5%	$9.0B+2.6%	$8.8B+6.1%	$8.3B+6.1%	$7.8B+3.9%	$7.5B+2.6%	$7.3B+1.0%	$7.2B-2.7%	$7.4B+2.0%	$7.3B+5.4%	$6.9B+6.0%	$6.5B+6.2%	$6.1B
Share Buybacks	$5.0B-22.6%	$6.5B+29.8%	$5.0B-31.9%	$7.4B-26.5%	$10.0B-9.1%	$11.0B+48.7%	$7.4B+48.0%	$5.0B-28.6%	$7.0B+34.6%	$5.2B+30.0%	$4.0B-13.0%	$4.6B-23.3%	$6.0B+0.3%	$6.0B+48.8%	$4.0B

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Operating Cash Flow	$5.1B+2.9%	$4.0B+9.2%	$5.0B+3.0%	$5.4B+25.7%	$5.0B-13.4%	$3.7B-9.4%	$4.8B-5.4%	$4.3B-12.3%
Depreciation & Amortization	$812.0M+12.3%	$785.0M+13.8%	$803.0M+13.7%	$761.0M+4.5%	$723.0M-5.0%	$690.0M-3.1%	$706.0M-2.1%	$728.0M+3.7%
Stock-Based Compensation	N/A	$132.0M+7.3%	$140.0M+2.9%	$121.0M+15.2%	N/A	$123.0M-22.2%	$136.0M-9.3%	$105.0M-16.0%
Capital Expenditures	$1.0B+2.7%	$1.0B+18.6%	$1.2B+26.2%	$1.2B+20.8%	$996.0M+27.2%	$859.0M+7.8%	$925.0M+13.2%	$993.0M+7.4%
Free Cash Flow	$4.1B+3.0%	$3.0B+6.3%	$3.8B-2.4%	$4.2B+27.2%	$4.0B-19.8%	$2.8B-13.5%	$3.9B-8.9%	$3.3B-16.8%
Investing Cash Flow	-$1.2B-12.5%	-$665.0M+8.4%	-$1.2B-33.3%	-$1.5B-38.5%	-$1.1B-105.2%	-$726.0M+4.7%	-$921.0M+8.1%	-$1.1B+9.3%
Financing Cash Flow	-$6.3B-74.4%	-$1.8B+56.7%	-$4.1B+26.6%	-$2.2B-253.2%	-$3.6B-44.7%	-$4.2B+1.3%	-$5.6B+7.9%	-$634.0M+68.9%
Dividends Paid	$2.6B+2.2%	$2.5B+4.0%	$2.5B+4.2%	$2.5B+4.3%	$2.6B+4.2%	$2.4B+6.5%	$2.4B+6.7%	$2.4B+6.8%
Share Buybacks	$875.0M+25.0%	$625.0M-53.7%	$2.3B-9.2%	$1.3B-35.5%	$700.0M-53.8%	$1.4B+36.9%	$2.5B+150.2%	$1.9B+29.3%

PG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

PG quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	50.2%-1.0pp	51.2%-0.2pp	51.4%+3.5pp	47.9%+0.4pp	47.4%-3.8pp	51.2%+0.9pp	50.3%+1.7pp	48.6%+0.2pp	48.5%-1.4pp	49.8%+0.4pp	49.4%+1.8pp	47.6%+80.4pp	-32.8%-2.4pp	-30.3%+15.5pp	-45.8%
Operating Margin	22.7%-1.6pp	24.3%+2.2pp	22.1%0.0pp	22.1%-0.1pp	22.2%-1.4pp	23.6%+1.5pp	22.1%+14.0pp	8.1%-11.9pp	20.0%-1.2pp	21.2%+0.9pp	20.3%+4.7pp	15.6%-31.7pp	47.3%+2.6pp	44.7%-1.2pp	45.9%
Net Margin	18.4%-0.5pp	18.9%+1.3pp	17.7%-0.2pp	17.9%-0.5pp	18.4%-0.4pp	18.8%+0.4pp	18.4%+12.6pp	5.8%-8.8pp	14.6%-9.0pp	23.6%+7.5pp	16.1%+6.1pp	10.0%-29.6pp	39.6%+0.9pp	38.7%+0.9pp	37.9%
Return on Equity	29.5%-1.0pp	30.6%+1.1pp	29.4%-1.7pp	31.1%-0.3pp	31.5%+0.8pp	30.7%+2.9pp	27.8%+19.6pp	8.2%-10.3pp	18.4%-9.0pp	27.5%+9.4pp	18.1%+7.0pp	11.2%-5.5pp	16.6%+0.2pp	16.5%-0.3pp	16.8%
Return on Assets	12.7%-0.1pp	12.8%+0.6pp	12.2%0.0pp	12.1%-0.4pp	12.6%+0.6pp	12.0%+1.2pp	10.8%+7.4pp	3.4%-4.9pp	8.2%-4.5pp	12.7%+4.5pp	8.3%+2.8pp	5.4%-2.6pp	8.1%-0.1pp	8.1%0.0pp	8.1%
Current Ratio	0.680.0x	0.700.0x	0.73+0.1x	0.630.0x	0.650.0x	0.70-0.2x	0.85+0.1x	0.75-0.1x	0.83-0.1x	0.88-0.2x	1.10+0.1x	1.00+0.1x	0.94+0.1x	0.80-0.1x	0.88
Debt-to-Equity	0.42-0.1x	0.480.0x	0.500.0x	0.520.0x	0.490.0x	0.500.0x	0.50+0.1x	0.430.0x	0.39+0.1x	0.320.0x	0.330.0x	0.290.0x	0.280.0x	0.28-0.1x	0.33
Asset Turnover	0.690.0x	0.670.0x	0.690.0x	0.680.0x	0.680.0x	0.64+0.1x	0.590.0x	0.590.0x	0.560.0x	0.540.0x	0.510.0x	0.55+0.3x	0.200.0x	0.210.0x	0.21
FCF Margin	17.4%+0.7pp	16.7%-3.0pp	19.7%+2.8pp	16.8%-0.1pp	16.9%-3.6pp	20.5%+0.3pp	20.2%+2.6pp	17.6%+0.9pp	16.7%+2.3pp	14.4%-4.2pp	18.6%+3.2pp	15.4%-19.0pp	34.4%-2.8pp	37.2%+4.4pp	32.8%

Metric	Q4'2610-K	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q
Gross Margin	48.5%-0.6pp	49.5%-1.5pp	51.2%-1.2pp	51.4%-0.7pp	49.1%-0.5pp	51.0%-0.2pp	52.4%-0.3pp	52.1%+0.1pp
Operating Margin	18.6%-2.2pp	21.6%-1.5pp	24.2%-2.1pp	26.2%-0.5pp	20.8%+1.9pp	23.1%+1.0pp	26.2%+5.6pp	26.7%+0.3pp
Net Margin	14.4%-2.9pp	18.5%-0.5pp	19.4%-1.7pp	21.2%+3.0pp	17.3%+2.0pp	19.1%+0.5pp	21.2%+5.0pp	18.2%-2.5pp
Return on Equity	5.6%-1.3pp	7.2%0.0pp	8.1%-0.9pp	8.9%+1.3pp	6.9%+0.7pp	7.2%-0.3pp	9.0%+1.9pp	7.6%-1.8pp
Return on Assets	2.4%-0.5pp	3.1%0.0pp	3.4%-0.4pp	3.7%+0.6pp	2.9%+0.3pp	3.1%-0.1pp	3.8%+0.9pp	3.1%-0.6pp
Current Ratio	0.680.0x	0.730.0x	0.720.0x	0.710.0x	0.700.0x	0.710.0x	0.76+0.1x	0.75+0.1x
Debt-to-Equity	0.42-0.1x	0.440.0x	0.480.0x	0.450.0x	0.480.0x	0.460.0x	0.490.0x	0.490.0x
Asset Turnover	0.170.0x	0.170.0x	0.170.0x	0.180.0x	0.170.0x	0.160.0x	0.180.0x	0.170.0x
FCF Margin	19.4%+0.3pp	14.2%-0.1pp	17.1%-0.7pp	18.8%+3.6pp	19.1%-5.1pp	14.4%-1.9pp	17.8%-2.2pp	15.2%-3.0pp

Note: The current ratio is below 1.0 (0.68), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Procter & Gamble Company PG	FY2026	$87.0B	$16.0B	18.4%	$351.3B	62/100
Kimberly-Clark Corp. KMB	FY2025	$16.4B	$2.0B	12.3%	$32.5B	52/100
Colgate-Palmolive Company CL	FY2025	$20.4B	$2.1B	10.5%	$70.4B	59/100
Kenvue Inc. KVUE	FY2025	$15.1B	$1.5B	9.7%	$34.0B	51/100
Church & Dwight Co., Inc. CHD	FY2025	$6.2B	$736.8M	11.9%	$23.3B	56/100

Where Procter & Gamble Company Ranks

Frequently Asked Questions

What is Procter & Gamble Company's annual revenue?

Procter & Gamble Company (PG) reported $87.0B in total revenue for fiscal year 2026. This represents a 3.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Procter & Gamble Company's revenue growing?

Procter & Gamble Company (PG) revenue grew by 3.3% year-over-year, from $84.3B to $87.0B in fiscal year 2026.

Is Procter & Gamble Company profitable?

Yes, Procter & Gamble Company (PG) reported a net income of $16.0B in fiscal year 2026, with a net profit margin of 18.4%.

What is Procter & Gamble Company's EBITDA?

Procter & Gamble Company (PG) had EBITDA of $22.9B in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Procter & Gamble Company have?

As of fiscal year 2026, Procter & Gamble Company (PG) had $9.9B in cash and equivalents against $22.8B in long-term debt.

What is Procter & Gamble Company's gross margin?

Procter & Gamble Company (PG) had a gross margin of 50.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Procter & Gamble Company's operating margin?

Procter & Gamble Company (PG) had an operating margin of 22.7% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Procter & Gamble Company's net profit margin?

Procter & Gamble Company (PG) had a net profit margin of 18.4% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does Procter & Gamble Company pay dividends?

Yes, Procter & Gamble Company (PG) paid $4.26 per share in dividends during fiscal year 2026.

What is Procter & Gamble Company's return on equity (ROE)?

Procter & Gamble Company (PG) has a return on equity of 29.5% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Procter & Gamble Company's free cash flow?

Procter & Gamble Company (PG) generated $15.1B in free cash flow during fiscal year 2026. This represents a 7.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Procter & Gamble Company's operating cash flow?

Procter & Gamble Company (PG) generated $19.6B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Procter & Gamble Company's total assets?

Procter & Gamble Company (PG) had $126.5B in total assets as of fiscal year 2026, including both current and long-term assets.

What are Procter & Gamble Company's capital expenditures?

Procter & Gamble Company (PG) invested $4.4B in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Procter & Gamble Company spend on research and development?

Procter & Gamble Company (PG) invested $2.1B in research and development during fiscal year 2026.

Does Procter & Gamble Company buy back shares?

Yes, Procter & Gamble Company (PG) spent $5.0B on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

How many shares does Procter & Gamble Company have outstanding?

Procter & Gamble Company (PG) had 2.32B shares outstanding as of fiscal year 2026.

What is Procter & Gamble Company's current ratio?

Procter & Gamble Company (PG) had a current ratio of 0.68 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

What is Procter & Gamble Company's debt-to-equity ratio?

Procter & Gamble Company (PG) had a debt-to-equity ratio of 0.42 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Procter & Gamble Company's return on assets (ROA)?

Procter & Gamble Company (PG) had a return on assets of 12.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Procter & Gamble Company's P/E ratio?

Procter & Gamble Company (PG) trades at 21.9x earnings, its market capitalization divided by net income of $16.0B net income, FY2026. The market capitalization is $351.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Procter & Gamble Company's price-to-sales ratio?

Procter & Gamble Company (PG) trades at 4.0x sales, its market capitalization divided by revenue of $87.0B revenue, FY2026. The market capitalization is $351.3B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Procter & Gamble Company's Altman Z-Score?

Procter & Gamble Company (PG) has an Altman Z-Score of 5.51, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Procter & Gamble Company's Piotroski F-Score?

Procter & Gamble Company (PG) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Procter & Gamble Company's earnings high quality?

Procter & Gamble Company (PG) has an earnings quality ratio of 1.22x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Procter & Gamble Company cover its interest payments?

Procter & Gamble Company (PG) has an interest coverage ratio of 22.52x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Procter & Gamble Company?

Procter & Gamble Company (PG) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.